MECLOFENAMATE SODIUM (meclofenamate sodium) by Viatris (2) is clinical pharmacology pharmacodynamics meclofenamate sodium is a nonsteroidal agent which has demonstrated anti-inflammatory, analgesic, and antipyretic activity in laboratory animals. Approved for idiopathic heavy menstrual blood loss (see, rheumatoid arthritis. First approved in 1986.
Drug data last refreshed 19h ago
CLINICAL PHARMACOLOGY Pharmacodynamics Meclofenamate sodium is a nonsteroidal agent which has demonstrated anti-inflammatory, analgesic, and antipyretic activity in laboratory animals. The mode of action, like that of other nonsteroidal anti-inflammatory agents, is not known. Therapeutic action…
Worked on MECLOFENAMATE SODIUM at Viatris (2)? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.